These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36598052)

  • 1. Attenuating endothelial leakiness with self-assembled DNA nanostructures for pulmonary arterial hypertension.
    Liu Q; Wu D; He B; Ding X; Xu Y; Wang Y; Zhang M; Qian H; Leong DT; Wang G
    Nanoscale Horiz; 2023 Jan; 8(2):270-278. PubMed ID: 36598052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial-cadherin downregulation as a feature of endothelial transdifferentiation in monocrotaline-induced pulmonary hypertension.
    Nikitopoulou I; Orfanos SE; Kotanidou A; Maltabe V; Manitsopoulos N; Karras P; Kouklis P; Armaganidis A; Maniatis NA
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L352-63. PubMed ID: 27233997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Muscle MLCK Contributes to Endothelial Cell Hyper-Proliferation through the ERK Pathway as a Mechanism for Vascular Remodeling in Pulmonary Hypertension.
    Anis M; Gonzales J; Halstrom R; Baig N; Humpal C; Demeritte R; Epshtein Y; Jacobson JR; Fraidenburg DR
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
    Born E; Lipskaia L; Breau M; Houssaini A; Beaulieu D; Marcos E; Pierre R; Do Cruzeiro M; Lefevre M; Derumeaux G; Bulavin DV; Delcroix M; Quarck R; Reen V; Gil J; Bernard D; Flaman JM; Adnot S; Abid S
    Circulation; 2023 Feb; 147(8):650-666. PubMed ID: 36515093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension.
    Cober ND; VandenBroek MM; Ormiston ML; Stewart DJ
    Hypertension; 2022 Aug; 79(8):1580-1590. PubMed ID: 35582968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.
    Le Vely B; Phan C; Berrebeh N; Thuillet R; Ottaviani M; Chelgham MK; Chaumais MC; Amazit L; Humbert M; Huertas A; Guignabert C; Tu L
    Am J Respir Cell Mol Biol; 2022 Aug; 67(2):215-226. PubMed ID: 35550008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATG101 Single-Stranded Antisense RNA-Loaded Triangular DNA Nanoparticles Control Human Pulmonary Endothelial Growth via Regulation of Cell Macroautophagy.
    Du J; Xu Z; Liu Q; Yang Y; Qian H; Hu M; Fan Y; Li Q; Yao W; Li H; Qian G; He B; Zhou D; Mao C; Wang G
    ACS Appl Mater Interfaces; 2017 Dec; 9(49):42544-42555. PubMed ID: 29154530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling.
    Cai D; Chen SY
    Redox Biol; 2022 Dec; 58():102524. PubMed ID: 36334380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.
    Aliotta JM; Pereira M; Amaral A; Sorokina A; Igbinoba Z; Hasslinger A; El-Bizri R; Rounds SI; Quesenberry PJ; Klinger JR
    Cardiovasc Res; 2013 Dec; 100(3):354-62. PubMed ID: 23867631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FGL2 prothrombinase contributes to the pathological process of experimental pulmonary hypertension.
    Fan C; Wang J; Mao C; Li W; Liu K; Wang Z
    J Appl Physiol (1985); 2019 Dec; 127(6):1677-1687. PubMed ID: 31580221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
    Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX
    Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of lung microvascular endothelial Piezo2 expression impairs NO synthesis, induces EndMT, and is associated with pulmonary hypertension.
    Tian S; Cai Z; Sen P; van Uden D; van de Kamp E; Thuillet R; Tu L; Guignabert C; Boomars K; Van der Heiden K; Brandt MM; Merkus D
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H958-H974. PubMed ID: 36149769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spermidine attenuates monocrotaline-induced pulmonary arterial hypertension in rats by inhibiting purine metabolism and polyamine synthesis-associated vascular remodeling.
    Chen YJ; Li HF; Zhao FR; Yu M; Pan SY; Sun WZ; Yin YY; Zhu TT
    Int Immunopharmacol; 2024 May; 132():111946. PubMed ID: 38552292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-4/11-Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension.
    Wu Y; Pan B; Zhang Z; Li X; Leng Y; Ji Y; Sun K; Chen AF
    Hypertension; 2022 Mar; 79(3):536-548. PubMed ID: 34984912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension.
    Ryanto GRT; Ikeda K; Miyagawa K; Tu L; Guignabert C; Humbert M; Fujiyama T; Yanagisawa M; Hirata KI; Emoto N
    Nat Commun; 2021 Mar; 12(1):1720. PubMed ID: 33741934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension.
    Yi D; Liu B; Wang T; Liao Q; Zhu MM; Zhao YY; Dai Z
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33804745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between endothelial function and micro-vascular remodeling measured by synchrotron radiation pulmonary micro-angiography in pulmonary arterial hypertension.
    Fuji S; Matsushita S; Hyodo K; Osaka M; Sakamoto H; Tanioka K; Miyakawa K; Kubota M; Hiramatsu Y; Tokunaga C
    Gen Thorac Cardiovasc Surg; 2016 Oct; 64(10):597-603. PubMed ID: 27393332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
    Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maresin-1 protects against pulmonary arterial hypertension by improving mitochondrial homeostasis through ALXR/HSP90α axis.
    Liu M; He H; Fan F; Qiu L; Zheng F; Guan Y; Yang G; Chen L
    J Mol Cell Cardiol; 2023 Aug; 181():15-30. PubMed ID: 37244057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.